3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Nasopharyngeal Carcinoma
2
Carcinoma, Non-Small-Cell Lung
2
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
Fluorouracil
7
Oxaliplatin
6
Nivolumab
5
Leucovorin
5
fludarabine
4
Cyclophosphamide
4
Capecitabine
4
zimberelimab
3
pembrolizumab
3
aldesleukin
3
Trastuzumab
3
Paclitaxel
3
Docetaxel
3
ulixertinib
2
trastuzumab deruxtecan
2
fludarabine phosphate
2
Specimen Handling
2
Ramucirumab
2
Irinotecan
2
zolbetuximab
1
zanidatamab
1
trifluridine tipiracil drug combination
1
trastuzumab biosimilar HLX02
1
trametinib
1
tislelizumab
1
sodium propionate
1
sapanisertib
1
relatlimab
1
quemliclustat
1
propionic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
Immune Checkpoint Inhibitors
×
30 days
×
Clear all
No trials found.